Indefinite Delivery Contract SPE2DU25D9215

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded an Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of the Department of Defense (DoD) and other federal government agencies. The contract, valued at up to $4,999,999.00, covers a wide portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This single-award IDC will enable the DLA to issue firm fixed-price delivery orders for pharmaceutical items to support the medical supply requirements of military healthcare facilities and veterans' medical centers nationwide through November 2036.

The contract was awarded as part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) solicitation, which aims to establish multiple regional contracts to provide worldwide pharmaceutical support to DoD customers, the U.S. Coast Guard, and other government agencies. The unrestricted, fully competitive acquisition will award contracts to responsive and responsible offerors whose proposals are technically acceptable and offer the lowest overall distribution fees. The solicitation is expected to be issued in March 2024 and remain open for 45 days, with a vendor conference scheduled prior to the closing date.